Parsabiv (Etelcalcetide) Vial
Branded
Parsabiv vial is used to treat increased amounts of a certain hormone (parathyroid) in people with long-term kidney disease who are on dialysis. Dialysis treatment usually causes higher than normal amounts of certain substances (such as parathyroid hormone, calcium, phosphorus) in your body. This medication works by decreasing how much parathyroid hormone your body makes. This effect helps lower calcium and phosphorus levels in your blood. Having the right amounts of parathyroid hormone, calcium, and phosphorus in your body can help prevent bone problems.
Uses Of Parsabiv Vial
- To treat increased amounts of a certain hormone (parathyroid)
Benefits Of Parsabiv Vial
In treatment of increased amounts of a certain hormone (parathyroid)
Parsabiv vial is used to treat secondary hyperparathyroidism (condition in which the body produces too much parathyroid hormone [PTH; natural substance needed to control the amount of calcium in the blood]) in adults with chronic kidney disease (condition in which the kidneys stop working slowly and gradually) who are being treated with dialysis (medical treatment to clean the blood when the kidneys are not working properly.) Parsabiv vial is in a class of medications called calcimimetics. It works by signaling the body to produce less parathyroid hormone in order to decrease the amount of calcium in the blood.
Side Effects Of Parsabiv Vial
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Parsabiv
- Nausea
- Vomiting
- Diarrhoea
- Muscle spasms
- Hypocalcaemia
How To Use Parsabiv Vial
Parsabiv vial comes as a solution (liquid) to inject intravenously (into a vein). It is usually given 3 times a week at the end of each dialysis session by a doctor or nurse at the dialysis center.
How Parsabiv Vial Works
Etelcalcetide is a calcimimetic agent that allosterically modulates the calcium-sensing receptor (CaSR). Etelcalcetide binds to the CaSR and enhances activation of the receptor by extracellular calcium. Activation of the CaSR on parathyroid chief cells decreases PTH secretion.
Disclaimer :The information provided on the website is intended to facilitate awareness about healthcare products and medical conditions generally but it is not a substitute for professional medical attention or advice. You should always speak with a qualified healthcare practitioner before taking any prescription or non-prescription drug. |